Here are some of the latest important developments and news about medicines and treatments (global + India) 👇 World Health Organization (WHO) adds key diabetes and weight-loss drugs to essential medicines.

• The WHO has included drugs like Semaglutide (used for type-2 diabetes, also helps with weight loss) in its 2025 Essential Medicines List.
• This may make such medications more affordable and easier to access worldwide — a significant shift, especially in countries like India, where diabetes and obesity are widespread.

New drug approvals and treatments progress in cancer, rare diseases, lung & kidney conditions.

• Brensocatib (marketed as Brinsupri) was approved in 2025 for the treatment of non-cystic fibrosis bronchiectasis, a serious chronic lung condition.
• Several new cancer treatments: targeted therapies for lung cancer, advanced lung cancer drugs, and other drugs approved for serious conditions.
• For example, Datopotamab deruxtecan has been approved for certain breast cancers, and its indication has recently expanded to certain lung cancers.

Emerging therapies for rare and difficult diseases

• Sebetralstat, an oral on-demand treatment for acute attacks of hereditary angioedema, got approval in mid-2025. (Wikipedia)
• New research-phase therapies are in the pipeline too: e.g., a drug candidate, Dovramilast, has received approval for investigational trials in certain immune reactions linked to leprosy, potentially helping with leprosy-related complications. (Medicines Development)

In India: regulatory changes, affordability, and concern over dangerous medicines

• The government has reportedly reduced the prices of 35 essential medicines (including commonly used ones like painkillers and statins), giving relief to many patients.
• However, there’s also alarming news: a spate of toxic cough syrups (some involving addictive or harmful substances) has triggered stricter government scrutiny. Recently, authorities in one state filed FIRs against over 120 pharma firms and seized illegal syrups.
• This reflects ongoing tension: while access and affordability improve, especially for important or emerging drugs, there remains a serious need for regulation and safety vigilance.

Promising research linking vaccines and neurological health

• A recent study by researchers at Stanford University suggests that a common vaccine (originally for shingles) could lower the risk of dementia or slow its progression. That could have big implications globally, given the aging population and rising dementia risk.

🔎 What This Means for Patients & the Public

• The inclusion of drugs like semaglutide in the WHO’s essential list could mean lower cost & wider availability globally, good news if you or someone you know deals with diabetes or weight-related conditions.
• New approvals and treatments offer hope for people with chronic or severe conditions (lung diseases, rare genetic disorders, some cancers). Treatment options are expanding.
• At the same time, the crackdown on unsafe cough syrups and illicit medicines is a reminder: it’s important to buy medicines only from trusted pharmacies, confirm prescriptions, and stay informed about recalls or regulatory updates.
• For India, the price reductions on essential medicines may make basic treatment more accessible — a potentially positive change for many people struggling with the cost of care.

If you like, I can also pull up 5–10 most important medicine-related research & drug-approval updates globally (past 6 months) so you get a compact “state-of-the-art” snapshot

Reference:

• Good News Today
• news.weill.cornell.edu

Medications that have been suggested by doctors worldwide are available on the link below
https://mygenericpharmacy.com/